TIMP1 and breast cancer: These discordant results evaluating the prognostic significance of TIMP-1 mRNA and protein in breast cancer might arise from the differences of method used for mRNA expression analysis, as well as the differences of antibodies and semiquantitative scoring criteria between the studies, or the play of chance.